Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.
about
Role of Dopamine 2 Receptor in Impaired Drug-Cue Extinction in Adolescent RatsDopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and FutureTemporal and spatial transcriptional fingerprints by antipsychotic or propsychotic drugs in mouse brainUnique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in RatsNovel Therapeutic GPCRs for Psychiatric Disorders.Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.Augmentation of clozapine with aripiprazole in severe psychotic bipolar and schizoaffective disorders: a pilot study.Calculating occupancy when one does not have baseline: a comparison of different optionsAripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats.Maintenance treatment in bipolar disorder: a focus on aripiprazole.Waterborne aripiprazole blunts the stress response in zebrafish.Quinoline- and isoquinoline-sulfonamide analogs of aripiprazole: novel antipsychotic agents?Aripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity.Decrease in tobacco consumption after treatment with topiramate and aripiprazole: a case report.History of substance abuse and risk of extrapyramidal side effects.A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disordersAcute Dystonia Following a Switch in Treatment from Atomoxetine to Low-dose AripiprazoleThe relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole.Adjunctive aripiprazole in bipolar I depression.Comparative analysis of pharmacological properties of xanomeline and N-desmethylclozapine in rat brain membranes.A Population Pharmacokinetic and Pharmacodynamic Analysis of RP5063 Phase 2 Study Data in Patients with Schizophrenia or Schizoaffective Disorder.The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [11C]-raclopride PET study with aripiprazole.
P2860
Q28273912-1CAF1652-377A-4921-8A51-448598F9C8BEQ28394341-57E4004A-1442-4C38-B4EE-297567FB04ADQ28543523-4D10659E-C1DC-4BBF-B489-36FAB6BB5928Q28546441-F9DEA645-05EE-4745-AC8F-C8A2CEA1108AQ30407406-F952FCBC-582B-4D95-80FE-9C77A0A83E0DQ33582063-D8903361-17C1-43BC-A3F5-C88B7DE4AA68Q34002264-092779A7-5209-4961-91F2-F1AD0174F537Q35208019-EC6AC5CC-4589-4B23-9CFC-007D20DBC891Q36846918-FAA3D3A9-BFDB-4C21-8C1D-11123B9851F9Q36902005-5F332FC2-D5F0-492B-9611-2FE0A2FC32BCQ37428054-EEB4F5DE-6A50-4B9E-A7E7-D58B5B72BAFEQ38172958-F2592574-91F0-4F35-8252-22B61C100ED3Q39244947-2FB92BD5-0EB6-488F-B8E5-62AC9A0485F0Q39302418-D965F01E-D737-4118-B541-75A7970A7A04Q41574680-29B976CD-00F1-4E02-9A88-E4CAF404A73DQ41981704-0703274B-45B4-4676-B0A0-FCF3DDE0D81AQ42828081-9A030D5A-1263-4901-AD0C-71A09CF4175AQ43922950-1F15EC0F-6450-403E-B51C-11F2C2FE3E48Q46055786-26871BA6-08C7-4BDB-A93C-C58FFE784E47Q48600420-00E8514E-BB53-4422-9EC3-9325248DA5C8Q52605626-B9E1B46B-2375-4924-A496-AC4637DEAF9AQ53403706-02D64BCE-6A73-4011-BE7F-22674AD062A0
P2860
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.
@ast
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.
@en
type
label
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.
@ast
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.
@en
prefLabel
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.
@ast
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.
@en
P356
P1476
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.
@en
P2093
Tetsuro Kikuchi
Tsuyoshi Hirose
P304
P356
10.2152/JMI.52.284
P478
P577
2005-11-01T00:00:00Z